Gene · 3556
Papers2,323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,323
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. | J Clin Invest | 2023 | 37733448 | PubTator, text mining | PubMed |
| Modulation of Neuroinflammation: Advances in Roles and Mechanisms of the IL-33/ST2 Axis Involved in Ischemic Stroke. | Neuroimmunomodulation | 2023 | 37729881 | PubTator, text mining | PubMed |
| Characterisation of IL-1 family members in Sweet syndrome highlights the overexpression of IL-1β and IL-1R3 as possible therapeutic targets. | Exp Dermatol | 2023 | 37724787 | PubTator, text mining | PubMed |
| The emerging roles of MARCH8 in viral infections: A double-edged Sword. | PLoS Pathog | 2023 | 37708148 | PubTator, text mining | PubMed |
| Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study. | Transl Cancer Res | 2023 | 37701118 | PubTator, text mining | PubMed |
| Constitutive photomorphogenic protein 1 ubiquitinates interleukin-1 receptor accessory protein in human liver cancer. | J Cancer Res Clin Oncol | 2023 | 37700160 | PubTator, text mining | PubMed |
| The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. | Int J Mol Sci | 2023 | 37686182 | PubTator, text mining | PubMed |
| Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review). | Med Int (Lond) | 2023 | 37680650 | PubTator, text mining | PubMed |
| Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. | Nat Commun | 2023 | 37679328 | PubTator, text mining | PubMed |
| Can CD34+CD38- lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children? | Front Pediatr | 2023 | 37675394 | PubTator, text mining | PubMed |
| CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them. | Hemasphere | 2023 | 37674860 | PubTator, text mining | PubMed |
| The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC. | Cancer Manag Res | 2023 | 37663894 | PubTator, text mining | PubMed |
| Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. | Front Immunol | 2023 | 37654497 | PubTator, text mining | PubMed |
| The characteristics and medical applications of antler stem cells. | Stem Cell Res Ther | 2023 | 37649124 | PubTator, text mining | PubMed |
| Correlations between IL-36 family cytokines in peripheral blood and subjective and objective assessment results in patients with allergic rhinitis. | Allergy Asthma Clin Immunol | 2023 | 37649097 | PubTator, text mining | PubMed |
| The emerging role of IL-38 in diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 37647430 | PubTator, text mining | PubMed |
| Targeted Therapy for EWS-FLI1 in Ewing Sarcoma. | Cancers (Basel) | 2023 | 37627063 | PubTator, text mining | PubMed |
| Advances in single-cell RNA sequencing and its applications in cancer research. | J Hematol Oncol | 2023 | 37612741 | PubTator, text mining | PubMed |
| Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury. | Neurotherapeutics | 2023 | 37610701 | PubTator, text mining | PubMed |
| Neuronal SAM68 differentially regulates alternative last exon splicing and ensures proper synapse development and function. | J Biol Chem | 2023 | 37595869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3556/papers?page=11